ProPhase Labs, Inc..
PRPH.US | Research and experimental development on natural sciences and engineering
ProPhase Labs, Inc. is a diversified biotech and genomics company. It focuses on developing and commercializing novel diagnostic and therapeutic solutions. The company operates through several divisions, including a CLIA-certified laboratory providing COVID-19 and other respiratory virus testing ser...Show More
Better Health for All
0
No evidence available to assess ProPhase Labs, Inc. on Better Health for All.
Fair Money & Economic Opportunity
0
ProPhase Labs, Inc. is a biotech and genomics company focused on diagnostic and therapeutic solutions, as well as dietary supplements. The provided articles discuss the formation of a clinical science advisory board, the development of a diagnostic test for esophageal disease, and a Nasdaq compliance extension.
1
There is no evidence in the articles or the company description to suggest that ProPhase Labs offers lending, deposit, or other financial services to consumers. Therefore, all KPIs related to 'Fair Money & Economic Opportunity' are scored as 0, indicating they are not applicable to the company's business model.
Fair Pay & Worker Respect
0
No evidence available to assess ProPhase Labs, Inc. on Fair Pay & Worker Respect.
Fair Trade & Ethical Sourcing
0
No specific quantitative data was found regarding fair trade certifications, audit frequency, forced or child labor incidents, supply chain traceability, remediation speed, ethical clause coverage in contracts, high-risk material spend, or supplier diversity spend.
1
While a Code of Business Conduct is in place, it does not provide quantitative metrics for these areas.
2
Overall ESG performance scores are mentioned, but these do not include specific data for the fair trade and ethical sourcing KPIs.
3
Honest & Fair Business
0
No specific, concrete data points were provided in the article to assess any of the KPIs for Honest & Fair Business. The article only outlines the existence of a non-retaliation policy for employees, without providing details on its strength, implementation, effectiveness, or any performance metrics required by the rubric.
1
Kind to Animals
0
The provided article indicates that ProPhase Labs plans to conduct animal studies and toxicology studies as part of its Linebacker-1 (LB-1) cancer co-therapy program, with completion expected by Q2 2023 and Q3 2023 respectively.
1
However, the article does not provide specific quantitative data points such as the number of animals used, the percentage of products certified cruelty-free, the extent of alternative testing methods employed, details on animal welfare policies, or investments in animal-free technologies. Therefore, no KPIs can be scored based on the available evidence.
No War, No Weapons
0
No evidence available to assess ProPhase Labs, Inc. on No War, No Weapons.
Planet-Friendly Business
-30
The company reported zero active regulatory compliance litigation cases.
1
In 2022, ProPhase Labs achieved a 27.5% reduction in packaging CO₂.
2
No publicly available carbon emissions data or reduction targets are provided.
3
Respect for Cultures & Communities
0
No specific data points or relevant information regarding ProPhase Labs' respect for cultures and communities, including formal partnerships, revenue reinvestment in local development, cultural impact assessments, local employment ratios, or grievance mechanisms, were found in the provided article.
1
Safe & Smart Tech
0
No evidence available to assess ProPhase Labs, Inc. on Safe & Smart Tech.
Zero Waste & Sustainable Products
0
No evidence available to assess ProPhase Labs, Inc. on Zero Waste & Sustainable Products.